Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

CLTCL1 Inhibitors

CLTCL1 Inhibitors refer to a specialized class of chemical compounds designed to selectively impede the activity of the CLTCL1 protein. CLTCL1, or Clathrin Heavy Chain-like 1, is a member of the clathrin heavy chain family, known for its role in membrane trafficking and vesicle formation within cells. The development of inhibitors targeting CLTCL1 is crucial for scientific investigations, providing researchers with specific tools to delve into the molecular functions and cellular processes associated with this particular protein. As part of the clathrin heavy chain family, CLTCL1 is likely involved in the assembly of clathrin-coated vesicles, essential for intracellular transport and the maintenance of cellular membrane dynamics.

The synthesis and optimization of CLTCL1 inhibitors demand a meticulous understanding of the protein's structural characteristics and its interactions within cellular pathways. These inhibitors are designed for specificity, aiming to selectively bind to key regions of CLTCL1 and disrupt its normal cellular functions. By utilizing CLTCL1 inhibitors in experimental contexts, scientists can investigate the consequences of protein inhibition on intracellular trafficking, shedding light on the specific roles played by CLTCL1 in cellular membrane dynamics and vesicle formation. The study of CLTCL1 inhibitors contributes to the broader understanding of clathrin-mediated processes, providing insights into the intricate molecular machinery that underlies essential cellular functions, such as endocytosis and the regulation of membrane-bound organelles.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D inhibits transcription by binding to DNA, thus preventing the synthesis of CLTCL1 mRNA.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide disrupts protein synthesis, leading to a reduction in CLTCL1 expression by inhibiting translation.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$40.00
$210.00
$816.00
$65.00
394
(15)

Puromycin induces premature termination of protein synthesis, impacting the translation process and lowering CLTCL1 levels.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$95.00
$322.00
$663.00
$1438.00
6
(1)

Rifampicin inhibits bacterial RNA polymerase, indirectly suppressing CLTCL1 expression by interfering with transcription.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$97.00
$254.00
36
(2)

Anisomycin hinders protein synthesis by blocking peptidyl transferase activity, resulting in reduced CLTCL1 synthesis.

Cordycepin

73-03-0sc-203902
10 mg
$99.00
5
(1)

Cordycepin interferes with mRNA synthesis, impacting transcription and contributing to the downregulation of CLTCL1.

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
$68.00
$261.00
8
(1)

Mycophenolic acid inhibits inosine monophosphate dehydrogenase, indirectly affecting CLTCL1 expression by disrupting purine synthesis.

Blasticidin S Hydrochloride

3513-03-9sc-204655A
sc-204655
25 mg
100 mg
$360.00
$475.00
20
(2)

Blasticidin S induces premature termination during translation, inhibiting protein synthesis and reducing CLTCL1 synthesis.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$36.00
$149.00
11
(1)

5-Fluorouracil interferes with RNA synthesis, affecting the expression of CLTCL1 by disrupting the production of mRNA.